Author:
Jackson Timothy L,Desai Riti,Wafa Hatem A,Wang Yanzhong,Peacock Janet,Peto Tunde,Chakravarthy Usha,Dakin Helen,Wordsworth Sarah,Lewis Cornelius,Clinch Patricia,Ramazzotto Lisa,Neffendorf James E,Lee Chan Ning,O'Sullivan Joe M,Reeves Barnaby C,Abugreen Salwa,Bindra Mandeep,Burton Ben,Dias Indra,Dinah Christiana,Gandhewar Ravikiran,Georgas Athanasios,Goverdhan Srinivas,Gulrez Ansari,Haynes Richard,Hughes Edward,Jackson (Chief Investigator) Timothy,Jafree Afsar,Joseph Sobha,Kashab Tarek,Membrey Luke,Menon Geeta,Misra Aseema,Narendran Niro,Newman Douglas,Patel Jignesh,Patra Sudeshna,Petrarca Robert,Priya Prakash,Rashi Arora,Salom Ramiro,Shah Paritosh,Shahrnaz Izadi,Sheen George,Shiew Marianne,Tesha Paul,Vrizidou Eleni
Funder
National Institute for Health and Care Research
Reference30 articles.
1. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis;Wong;Lancet Glob Health,2014
2. Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013;Quartilho;Eye (Lond),2016
3. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study;Bourne;Lancet Glob Health,2020
4. Incidence and outcomes of infectious and noninfectious endophthalmitis after intravitreal injections for age-related macular degeneration;Daien;Ophthalmology,2018
5. Cost impact of different treatment regimens of brolucizumab in neovascular age-related macular degeneration: a budget impact analysis;Siddiqui;J Manag Care Spec Pharm,2022